Icecure Medical Ltd stock is traded at $0.7001, with a volume of 44,677. It is down -5.66% in the last 24 hours and down -35.18% over the past month. Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Previous Close:
$0.7421
Open:
$0.74
24h Volume:
44,677
Relative Volume:
0.29
Market Cap:
$3.25M
Revenue:
$3.57M
Net Income/Loss:
-$15.74M
P/E Ratio:
-
EPS:
-$6.95
Net Cash Flow:
-$15.77M
1W Performance:
+1.48%
1M Performance:
-35.18%
6M Performance:
-90.28%
1Y Performance:
-96.70%
1-Day Range:
$0.7$0.74
1-Week Range:
$0.68$0.9499
52-Week Range:
$0.65$22.50
Icecure Medical Ltd Stock (ICCM) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS